RDY
Dr. Reddy’s Laboratories Ltd ADRNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$11.12B
P/E Ratio
24.74
EPS
$0.54
Beta
0.26
52W High
$15.79
52W Low
$12.19
50-Day MA
$13.34
200-Day MA
$13.87
Dividend Yield
0.62%
Profit Margin
12.80%
Forward P/E
24.88
PEG Ratio
1.60
About Dr. Reddy’s Laboratories Ltd ADR
Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company. The company is headquartered in Hyderabad, India.
Fundamentals
| Revenue (TTM) | $335.93B |
| Gross Profit (TTM) | $177.26B |
| EBITDA | $68.15B |
| Operating Margin | 1.54% |
| Return on Equity | 11.80% |
| Return on Assets | 5.74% |
| Revenue/Share (TTM) | $67.39 |
| Book Value | $0.79 |
| Price-to-Book | 2.80 |
| Price-to-Sales (TTM) | 0.03 |
| EV/Revenue | 3.129 |
| EV/EBITDA | 13.28 |
| Quarterly Earnings Growth (YoY) | -86.20% |
| Quarterly Revenue Growth (YoY) | -11.60% |
| Shares Outstanding | $832.70M |
| Float | $3.59B |
| % Insiders | 0.00% |
| % Institutions | 15.29% |
Historical Volatility
HV 10-Day
20.25%
HV 20-Day
17.47%
HV 30-Day
28.89%
HV 60-Day
29.94%
HV Rank
77.0%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.24 target)
2
Buy2
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 6/13/2026